118 related articles for article (PubMed ID: 7735558)
61. Expression of multidrug resistance-associated protein (MRP) mRNA in blast cells from acute myeloid leukemia (AML) patients.
Ross DD; Doyle LA; Schiffer CA; Lee EJ; Grant CE; Cole SP; Deeley RG; Yang W; Tong Y
Leukemia; 1996 Jan; 10(1):48-55. PubMed ID: 8558937
[TBL] [Abstract][Full Text] [Related]
62. Expression of multidrug resistance (mdr) gene(s) in primary lymphoid organs of chicken immune system during embryonic development.
Petrini M; Galimberti S; Sabbatini A; Bianchi F; Bernardini N; Dolfi A; Lupetti M
Experientia; 1995 Feb; 51(2):137-40. PubMed ID: 7875253
[TBL] [Abstract][Full Text] [Related]
63. Sensitization of multidrug resistant human ostesarcoma cells to Apo2 Ligand/TRAIL-induced apoptosis by inhibition of the Akt/PKB kinase.
Cenni V; Maraldi NM; Ruggeri A; Secchiero P; Del Coco R; De Pol A; Cocco L; Marmiroli S
Int J Oncol; 2004 Dec; 25(6):1599-608. PubMed ID: 15547696
[TBL] [Abstract][Full Text] [Related]
64. Differential utilization of multiple transcription start points accompanies the overexpression of the P-glycoprotein-encoding gene in Chinese hamster lung cells.
Ince TA; Scotto KW
Gene; 1995 Apr; 156(2):287-90. PubMed ID: 7758970
[TBL] [Abstract][Full Text] [Related]
65. Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas.
Holzmayer TA; Hilsenbeck S; Von Hoff DD; Roninson IB
J Natl Cancer Inst; 1992 Oct; 84(19):1486-91. PubMed ID: 1359152
[TBL] [Abstract][Full Text] [Related]
66. Increased AP-1 activity in drug resistant human breast cancer MCF-7 cells.
Daschner PJ; Ciolino HP; Plouzek CA; Yeh GC
Breast Cancer Res Treat; 1999 Feb; 53(3):229-40. PubMed ID: 10369069
[TBL] [Abstract][Full Text] [Related]
67. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
[TBL] [Abstract][Full Text] [Related]
68. Expression of MDR1/P glycoprotein in human sarcomas.
Vergier B; Cany L; Bonnet F; Robert J; de Mascarel A; Coindre JM
Br J Cancer; 1993 Dec; 68(6):1221-6. PubMed ID: 7903154
[TBL] [Abstract][Full Text] [Related]
69. Establishment and characterization of adriamycin-resistant human colorectal adenocarcinoma HCT-15 cell lines with multidrug resistance.
Uchiyama-Kokubu N; Watanabe T
Anticancer Drugs; 2001 Oct; 12(9):769-79. PubMed ID: 11593059
[TBL] [Abstract][Full Text] [Related]
70. Anomalous expression of P-glycoprotein in highly drug-resistant human KB cells.
Dolci ED; Abramson R; Xuan Y; Siegfried J; Yuenger KA; Yassa DS; Tritton TR
Int J Cancer; 1993 May; 54(2):302-8. PubMed ID: 8098016
[TBL] [Abstract][Full Text] [Related]
71. Spontaneous reversal of p-glycoprotein expression in multidrug resistant cell lines.
Gréen H; Lotfi K; Zackrisson AL; Peterson C
Pharmacol Toxicol; 2003 Dec; 93(6):297-304. PubMed ID: 14675464
[TBL] [Abstract][Full Text] [Related]
72. Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123.
Ludescher C; Thaler J; Drach D; Drach J; Spitaler M; Gattringer C; Huber H; Hofmann J
Br J Haematol; 1992 Sep; 82(1):161-8. PubMed ID: 1358171
[TBL] [Abstract][Full Text] [Related]
73. Expression of MDR1 mRNA and encoding P-glycoprotein in archival formalin-fixed paraffin-embedded gall bladder cancer tissues.
Cao L; Duchrow M; Windhövel U; Kujath P; Bruch HP; Broll R
Eur J Cancer; 1998 Sep; 34(10):1612-7. PubMed ID: 9893638
[TBL] [Abstract][Full Text] [Related]
74. Genetic transfer of non-P-glycoprotein-mediated multidrug resistance (MDR) in somatic cell fusion: dissection of a compound MDR phenotype.
Eijdems EW; Borst P; Jongsma AP; de Jong S; de Vries EG; van Groenigen M; Versantvoort CH; Nieuwint AW; Baas F
Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3498-502. PubMed ID: 1348862
[TBL] [Abstract][Full Text] [Related]
75. Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.
Chao CC
FEBS Lett; 1995 Oct; 373(3):285-90. PubMed ID: 7589484
[TBL] [Abstract][Full Text] [Related]
76. Correlation of expression levels of P-glycoprotein with resistance to adriamycin in a renal adenocarcinoma cell line.
Kawamoto S; Deguchi T; Nezesa S; Yamada S; Okano M; Kawada Y
Urol Res; 1997; 25(6):407-12. PubMed ID: 9443650
[TBL] [Abstract][Full Text] [Related]
77. Downregulation of PGY1/MDR1 mRNA level in human KB cells by antisense oligonucleotide conjugates. RNA accessibility in vitro and intracellular antisense activity.
Kostenko EV; Laktionov PP; Vlassov VV; Zenkova MA
Biochim Biophys Acta; 2002 Jun; 1576(1-2):143-7. PubMed ID: 12031494
[TBL] [Abstract][Full Text] [Related]
78. Multidrug resistance genes and p-glycoprotein in the testis of the rat, mouse, Guinea pig, and human.
Melaine N; Liénard MO; Dorval I; Le Goascogne C; Lejeune H; Jégou B
Biol Reprod; 2002 Dec; 67(6):1699-707. PubMed ID: 12444043
[TBL] [Abstract][Full Text] [Related]
79. P-glycoprotein subcellular localization and cell morphotype in MDR1 gene-transfected human osteosarcoma cells.
Maraldi NM; Zini N; Santi S; Scotlandi K; Serra M; Baldini N
Biol Cell; 1999 Jan; 91(1):17-28. PubMed ID: 10321019
[TBL] [Abstract][Full Text] [Related]
80. Activity of P-glycoprotein in B-cell chronic lymphocytic leukemia determined by a flow cytometric assay.
Ludescher C; Hilbe W; Eisterer W; Preuss E; Huber C; Gotwald M; Hofmann J; Thaler J
J Natl Cancer Inst; 1993 Nov; 85(21):1751-8. PubMed ID: 8105101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
